3Obal FJr, Payne L, Kacsoh B, et al. Involvement of prolactin in the REM sleep-promoting activity of systemic vasoactive intestinal peptide(VIP). Brain Res, 1994,645:143～149
4Drucker-colin R, Bernal-Pedraza J, Fernandez-Cancinof, et al. Is vasoactive intestinal polypeptide (VIP) a sleep factor? Peptides, 1984,5(4):834～840
5Mirmiran M, Kruisbrink J, Bos N P, et al. Decrease of rapid-eye-movement sleep in the light by intraventricular application of a VIP-antagonist in the rat. Brain Res, 1988,458(1):192～194
6Murck H, Guldner J, Colla-Muller M, et al. VIP decelerates non-REM-REM cycles and modulates hormone secretion during sleep in men. Am J Physiol, 1996,271(4 Pt 2):R905～R911
7Schonenberger G A, Maier P F, Tobler H J, et al. A naturally occurring delta-EEG enhancing nonapeptide in rabbits.X.Final isolation, characterization and activity test. Pflugers Arch, 1977,369:99～109
8Card J P, Fitzpatrick-McElligott S, Gozes I, et al. Localization of vasopressin, vasoactive intestinal polypeptide, peptide histidine isoleucine and somatostatin-mRNA in rat suprachiasmatic nucleus. Cell Tissue Res, 1988,252:307～315
9Czeisler C A, Zimmerman J C, Ronda J M, et al. Timing of REM sleep is coupled to the circadian rhythm of body temperature in man. Sleep, 1988,2:329～346
10Fischer J, Jackowski M. The significance of vasoactive intestinal polypeptide (VIP) in diagnosis of sleep apnea syndrome. Pneumologie, 1989,43(suppl 1):584～586
